Butyrogenic bacteria after acute graft-versus-host disease (GVHD) are associated with the development of steroid-refractory GVHD

• Jonathan L. Golob,
• Martha M. DeMeules,
• Tillie Loeffelholz,
• Z.Z. Quinn,
• Michael K. Dame,
• Sabrina S. Silvestri,
• Michael C. Wu,
• Thomas M. Schmidt,
• Tina L. Fiedler,
• Matthew J. Hoostal,
• Marco Mielcarek,
• Jason Spence,
• Steven A. Pergam,
• David N. Fredricks

Affiliations

Jonathan L. Golob

Division of Infectious Diseases, Department of Medicine, University of Michigan, Ann Arbor, MI;; Jonathan L Golob, University of Michigan, 1510E MSRB I, 1150 West Medical Center Dr, SPC 5666, Ann Arbor, MI 48109-5666;

Martha M. DeMeules

Infectious Disease Sciences, Vaccines and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA;

Tillie Loeffelholz

Infectious Disease Sciences, Vaccines and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA;

Z.Z. Quinn

Infectious Disease Sciences, Vaccines and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA;

Michael K. Dame

Department of Internal Medicine, University of Michigan, Ann Arbor, MI

Sabrina S. Silvestri

Department of Internal Medicine, University of Michigan, Ann Arbor, MI

Michael C. Wu

Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA

Thomas M. Schmidt

Division of Infectious Diseases, Department of Medicine, University of Michigan, Ann Arbor, MI;

Tina L. Fiedler

Infectious Disease Sciences, Vaccines and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA;

Matthew J. Hoostal

Division of Infectious Diseases, Department of Medicine, University of Michigan, Ann Arbor, MI;

Marco Mielcarek

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA

Jason Spence

Department of Internal Medicine, University of Michigan, Ann Arbor, MI; Department of Cell and Developmental Biology, University of Michigan, Ann Arbor, MI;; Department of Biomedical Engineering, University of Michigan College of Engineering, Ann Arbor, MI

Steven A. Pergam

Infectious Disease Sciences, Vaccines and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA;; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA; Division of Allergy & Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA

David N. Fredricks

Infectious Disease Sciences, Vaccines and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA;; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA; Division of Allergy & Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA